If you’re a generally healthy adult, you almost certainly don’t need a vitamin D blood test, and you probably don’t need a high-dose supplement. I’d rather you keep the $25 to $100 a lab would charge and spend it on something useful.
Vitamin D’s main job is helping your body absorb calcium and maintain bone. The usual blood test, 25-hydroxyvitamin D or 25(OH)D, measures the form you have in storage. It does not directly measure bone strength, immune health, or mood, which is why a low result often promises more information than it delivers.
What the large trials found
For generally healthy adults, vitamin D supplements do not prevent fractures, heart attacks, or strokes. VITAL followed nearly 26,000 Americans for more than five years and found no meaningful difference between people taking 2,000 IU daily and those taking a placebo. D-Health followed more than 21,000 older Australians using a large monthly dose and reached the same conclusion. When researchers later combined 13 trials involving more than 86,000 people, fractures were no less common with vitamin D.
The one age group that may benefit is adults 75 and older. Across 25 trials, daily supplementation produced a small reduction in deaths, with an average dose of about 900 IU. That benefit has not appeared in younger, generally healthy adults.
The cancer evidence is less settled. Supplements did not lower the chance of developing cancer, although some analyses suggest that modest daily doses might slightly reduce cancer deaths. Large monthly doses did not show the same pattern, and no trial has directly compared the two schedules. That is an interesting signal, but not a reason to take vitamin D for cancer prevention.
Where supplements may help
The clearest benefit is in adults with high-risk prediabetes. Across three trials, vitamin D reduced progression to type 2 diabetes by 15 percent over three years, or about three fewer cases for every 100 people treated. The average dose across the broader evidence was about 3,500 IU daily.
The autoimmune finding is more tentative. VITAL reported 22 percent fewer diagnoses among people taking vitamin D, but it grouped several very different illnesses together, and the benefit disappeared within two years of stopping the supplement. So while the result deserves more study, it is not strong enough to guide a decision on its own.
Why a low result can mislead
About 24 percent of U.S. adults have levels below 20 nanograms per milliliter, and roughly 6 percent fall below 10. Lower levels are more common with darker skin, limited sun exposure, northern winters, obesity, inactivity, and chronic illness. But a low level can be a marker of poor health rather than its cause. Raising the number does not necessarily fix what drove it down, which helps explain why supplementation trials in generally healthy adults have been disappointing.
The evidence is thinnest for people with severe deficiency, usually defined as below 10 to 12 nanograms per milliliter. No large fracture or mortality trial has focused only on that group, and withholding treatment long enough to run one would be difficult to justify.
Even the number itself has limits. Different 25(OH)D tests can disagree by 10 to 20 percent, so chasing a precise target is unreliable. Claims that everyone should reach 40 to 60 nanograms per milliliter come from observational studies and expert opinion, not randomized trials. The National Academy of Medicine considers 20 adequate for bone health, while levels above 50 may carry risk.
Who should test, and who should supplement
If you are 19 to 74 and feel well, I would not order a screening test. The U.S. Preventive Services Task Force says the evidence is insufficient to support screening adults without symptoms, and the Endocrine Society recommends against routine testing in healthy people of any age.
If you are 75 or older, I would skip the test and take a modest daily supplement instead. The trials averaged about 900 IU daily, although doses varied. I would choose daily D3 over a large monthly dose, because large intermittent doses may increase falls and possibly cancer mortality.
If you have high-risk prediabetes, a conversation about a higher dose is reasonable; the trials averaged about 3,500 IU daily. You can read more about how I think about prediabetes risk in the guide to A1C.
Testing does make sense when the result could change treatment: osteoporosis, poor nutrient absorption from celiac disease or bariatric surgery, chronic kidney disease, bone pain or muscle weakness, or use of anticonvulsants or long-term glucocorticoids. Sarcoidosis is a special case. Testing helps a clinician judge whether supplementation is safe, because the disease can make vitamin D raise calcium to dangerous levels. I would not take high-dose vitamin D for sarcoidosis without medical supervision.
For everyone else, the recommended daily allowance is enough: 600 IU through age 70 and 800 IU after that. A standard multivitamin or a few servings of fortified food will usually get you there. If you buy a supplement, look for USP or NSF verification; independent testing has found that many over-the-counter products miss the dose printed on the label.
The practical distinction is between meeting your ordinary daily need and chasing a high blood level. Most adults should do the first and skip the second.